There are 2789 resources available
1325P - Checkpoint inhibitor monotherapy in potentially study-eligible or non-study-eligible NSCLC patients in the German CRISP registry real-world cohort (AIO-TRK-0315)
Presenter: Frank Griesinger
Session: ePoster Display
1474P - Patient characteristics and treatment patterns in patients with metastatic pancreatic cancer by BRCA/ATM status in the PRIOR-2 study
Presenter: Maria Sierra
Session: ePoster Display
1327P - Impact of bone targeted agents (BTA) in advanced non-small cell lung cancer (aNSCLC) patients (pts) with high bone tumor burden (HBTB) treated with PD(L)1 inhibitors (ICIs)
Presenter: Sara Manglaviti
Session: ePoster Display
1328P - Outcomes from local consolidative therapy and immune checkpoint inhibitors in metastatic non-small cell lung cancer
Presenter: Lingzhi Hong
Session: ePoster Display
1174P - Preliminary prediction of EGFR-mutant non-small cell lung cancer outcome using radiomic signature
Presenter: Jose Minatta
Session: ePoster Display
Resources:
Abstract
1175P - Predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated on the Pacific regimen
Presenter: Robert Gao
Session: ePoster Display
1176P - Neoadjuvant PD-1 inhibitor (toripalimab) plus chemotherapy in patients with potentially resectable NSCLC: An open-label, single-arm, phase II trial
Presenter: Xinsheng Zhu
Session: ePoster Display
1177P - Real-world treatment patterns and outcomes in stage III non-small cell lung cancer (NSCLC): Middle East and Africa (MEA)-KINDLE study
Presenter: Abdul Rahman Jazieh
Session: ePoster Display
1178P - Senescence signature affects overall survival in non-small cell lung cancer
Presenter: Andreas Domen
Session: ePoster Display
1179P - The effect of neoadjuvant chemotherapy / chemoradiotherapy on tumor tissue PD-L1 and VISTA expression levels in non-small cell lung cancers (NSCLC)
Presenter: Orhun Akdogan
Session: ePoster Display